Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to 0.37.

  • Fortress Biotech's Asset Utilization Ratio fell 2033.28% to 0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year decrease of 2033.28%. This contributed to the annual value of 0.37 for FY2024, which is 109.7% up from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Asset Utilization Ratio is 0.37, which was down 2033.28% from 0.35 recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Asset Utilization Ratio registered a high of 0.53 during Q2 2024, and its lowest value of 0.12 during Q1 2021.
  • In the last 5 years, Fortress Biotech's Asset Utilization Ratio had a median value of 0.28 in 2023 and averaged 0.32.
  • As far as peak fluctuations go, Fortress Biotech's Asset Utilization Ratio plummeted by 3542.16% in 2021, and later skyrocketed by 12476.49% in 2024.
  • Fortress Biotech's Asset Utilization Ratio (Quarter) stood at 0.17 in 2021, then surged by 42.1% to 0.24 in 2022, then soared by 118.62% to 0.53 in 2023, then decreased by 19.99% to 0.43 in 2024, then decreased by 14.13% to 0.37 in 2025.
  • Its Asset Utilization Ratio was 0.37 in Q3 2025, compared to 0.35 in Q2 2025 and 0.36 in Q1 2025.